Total Payments
$111,246
2024 Payments
$29,246
Companies
24
Transactions
390
Medicare Patients
3,524
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$96,981 (87.2%)
Food & Beverage$10,389 (9.3%)
Consulting$2,123 (1.9%)
Travel$1,658 (1.5%)
Education$95.19 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $96,981 | 56 | 87.2% |
| Food and Beverage | $10,389 | 315 | 9.3% |
| Consulting Fee | $2,123 | 2 | 1.9% |
| Travel and Lodging | $1,658 | 4 | 1.5% |
| Education | $95.19 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $58,368 | 195 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29,143 | 57 | $0 (2024) |
| Allergan Inc. | $15,627 | 30 | $0 (2019) |
| ITI, Inc. | $6,648 | 29 | $0 (2023) |
| Alkermes, Inc. | $413.00 | 17 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $151.27 | 9 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $145.33 | 8 | $0 (2022) |
| Celgene Corporation | $139.18 | 12 | $0 (2019) |
| ABBVIE INC. | $91.97 | 4 | $0 (2023) |
| Nestle HealthCare Nutrition Inc. | $60.46 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,246 | 61 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($29,143) |
| 2023 | $6,981 | 44 | ITI, Inc. ($6,648) |
| 2022 | $1,106 | 52 | Sunovion Pharmaceuticals Inc. ($776.35) |
| 2021 | $2,768 | 32 | Sunovion Pharmaceuticals Inc. ($2,735) |
| 2020 | $2,091 | 22 | Sunovion Pharmaceuticals Inc. ($2,001) |
| 2019 | $12,443 | 41 | Sunovion Pharmaceuticals Inc. ($7,580) |
| 2018 | $31,714 | 78 | Sunovion Pharmaceuticals Inc. ($25,024) |
| 2017 | $24,896 | 60 | Sunovion Pharmaceuticals Inc. ($20,251) |
All Payment Transactions
390 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CNS | ||||||
| 12/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $671.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: CNS | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $120.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: CNS | ||||||
| 10/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.58 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $111.01 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: PSYCHIATRY | ||||||
| 09/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 949 | 3,470 | $963,639 | $380,277 |
| 2022 | 2 | 858 | 3,347 | $926,628 | $376,029 |
| 2021 | 2 | 849 | 3,469 | $913,016 | $401,520 |
| 2020 | 2 | 868 | 3,758 | $653,731 | $339,656 |
Total Patients
3,524
Total Services
14,044
Medicare Billing
$1.5M
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 849 | 3,370 | $927,557 | $363,765 | 39.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 100 | 100 | $36,082 | $16,512 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 793 | 3,282 | $903,266 | $365,270 | 40.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 65 | 65 | $23,362 | $10,759 | 46.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 788 | 3,408 | $891,637 | $391,285 | 43.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 61 | 61 | $21,379 | $10,235 | 47.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 812 | 3,702 | $640,967 | $332,821 | 51.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 56 | 56 | $12,764 | $6,834 | 53.5% |
About Dr. Alexander Pinkusovich, MD
Dr. Alexander Pinkusovich, MD is a Psychiatry healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801850003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Pinkusovich, MD has received a total of $111,246 in payments from pharmaceutical and medical device companies, with $29,246 received in 2024. These payments were reported across 390 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($96,981).
As a Medicare-enrolled provider, Pinkusovich has provided services to 3,524 Medicare beneficiaries, totaling 14,044 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Brooklyn, NY
- Active Since 04/14/2006
- Last Updated 05/05/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801850003
Products in Payments
- LATUDA (Drug) $58,365
- CAPLYTA (Drug) $35,791
- VRAYLAR (Drug) $15,552
- LYBALVI (Drug) $413.00
- XIFAXAN (Drug) $193.52
- NAMZARIC (Drug) $146.60
- NASCOBAL (Drug) $145.33
- ZENPEP (Drug) $60.46
- SILENOR (Drug) $56.52
- OPZELURA (Drug) $52.87
- ZTLido (Drug) $46.21
- SPRAVATO (Drug) $39.29
- Vascepa (Drug) $34.50
- JANUVIA (Drug) $32.62
- Otezla (Drug) $26.44
- Trulance (Drug) $25.00
- ADVAIR (Drug) $23.53
- Amitiza (Drug) $21.69
- Dayvigo (Drug) $21.14
- VIIBRYD (Drug) $20.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brooklyn
Dr. Mark Owens, Do, DO
Psychiatry — Payments: $502,442
Psychiatry $502,442
Dr. Nancy Abdel-Wahab, M.d, M.D
Psychiatry — Payments: $194,999
Psychiatry $194,999
Louis Belzie, Md, Phd, MD, PHD
Psychiatry — Payments: $178,082
Psychiatry $178,082
Dr. Mark Gurtovy, M.d, M.D
Psychiatry — Payments: $31,729
Psychiatry $31,729
Thresiamma Nidhiry, Md, MD
Psychiatry — Payments: $27,833
Psychiatry $27,833
Dr. Irina Kiblitsky, M.d, M.D
Psychiatry — Payments: $22,079
Psychiatry $22,079